Determining optimal maintenance schedules for adjuvant intravesical bacillus Calmette–Guerin immunotherapy in non-muscle-invasive bladder cancer: a systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Determining optimal maintenance schedules for adjuvant intravesical bacillus Calmette–Guerin immunotherapy in non-muscle-invasive bladder cancer: a systematic review and network meta-analysis

Published:2017-06-06 Issue:8 Volume:33 Page:1379-1387
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Huang Zixiong¹,Liu Huixin²,Wang Yizeng³,Zhang Chunfang²,Xu Tao¹

Affiliation:

1. Department of Urology, Peking University People’s Hospital, Beijing, China;

2. Department of Clinical Epidemiology, Peking University People’s Hospital, Beijing, China;

3. Department of Vascular Surgery, Peking University People’s Hospital, Beijing, China

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2017.1326889

Reference44 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Epidemiology and Risk Factors of Urothelial Bladder Cancer

3. EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

4. Intravesical bacille calmette-guérin versus mitomycin c in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression

5. Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: A Meta-analysis of the Published Results of Randomized Clinical Trials

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of intravesical Bacillus Calmette-Guerin in patients with non-muscle invasive bladder cancer: a retrospective study in Australia;Frontiers in Urology;2024-02-14

2. Risk stratification and management of non‐muscle‐invasive bladder cancer: A physician survey in six Asia‐Pacific territories;International Journal of Urology;2023-10-06

3. Efficacy of Different Bacillus of Calmette-Guérin (BCG) Strains on Recurrence Rates among Intermediate/High-Risk Non-Muscle Invasive Bladder Cancers (NMIBCs): Single-Arm Study Systematic Review, Cumulative and Network Meta-Analysis;Cancers;2023-03-23

4. Fremantle protocol: Multicenter clinical outcomes for a pragmatic protocol for intravesical bacillus Calmette–Guerin;Asia-Pacific Journal of Clinical Oncology;2023-01-19

5. Effects of intravesical BCG maintenance therapy duration on recurrence rate in high-risk non-muscle invasive bladder cancer (NMIBC): Systematic review and network meta-analysis according to EAU COVID-19 recommendations;PLOS ONE;2022-09-08